RisKlick SA

The core activity of Risklick is the development and provision of artificial intelligence (AI)-based solutions for clinical research and development, particularly for the creation and management of clinical trial protocols. The company offers a software platform that enables the rapid and efficient development, management, and implementation of clinical trial protocols and plans. The platform leverages a comprehensive database and generative AI to facilitate collaboration between researchers, clinical trial centers, and other stakeholders, and to accelerate the time-to-market of new treatments.